Fusion of the RET kinase domain with several N-terminal partners such as kinesin family 5B (KIF5B) or coiled-coil domain-containing 6 (CCDC6) occurs in approximately 70% of patients with RET fusion-positive non-small cell lung cancer (NSCLC)5. This evidence concerns the gene KIF5B and non-small cell lung carcinoma.